Effect of Ketogenic Diet on Obesity and Other Metabolic Disorders: Narrative Review

References

• Vasileva LV, Marchev AS, Georgiev MI. Causes and solutions to “globesity”: the new fa (s) t alarming global epidemic. Food Chem Toxicol. 2018;121:173–193. doi:10.1016/j.fct.2018.08.071
   PubMed Web of Science ®Google Scholar
• Collaborators GO. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.
   PubMed Web of Science ®Google Scholar
• Nymo S, Coutinho S, Jørgensen J, et al. Timeline of changes in appetite during weight loss with a ketogenic diet. Int J Obesity. 2017;41(8):1224–1231. doi:10.1038/ijo.2017.96
   Web of Science ®Google Scholar
• Meex RC, Blaak EE, van Loon LJ. Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes. Obesity Rev. 2019;20(9):1205–1217. doi:10.1111/obr.12862
   PubMed Web of Science ®Google Scholar
• Engin A. The definition and prevalence of obesity and metabolic syndrome. Obes Lipotoxic. 2017;3:1–17.
   Google Scholar
• World Health Organization. Obesity and Overweight Fact Sheet. Geneva: World Health Organization; 2018.
   Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-0
   PubMed Web of Science ®Google Scholar
• Williams EP, Mesidor M, Winters K, Dubbert PM, Wyatt SB. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Curr Obesity Rep. 2015;4(3):363–370. doi:10.1007/s13679-015-0169-4
   PubMed Web of Science ®Google Scholar
• Wyatt SB, Winters KP, Dubbert PM. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am J Med Sci. 2006;331(4):166–174. doi:10.1097/00000441-200604000-00002
   PubMed Web of Science ®Google Scholar
• Heymsfield SB, Wadden TA, Longo DL. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(3):254–266. doi:10.1056/NEJMra1514009
   PubMed Web of Science ®Google Scholar
• Patel JJ, Rosenthal MD, Miller KR, Codner P, Kiraly L, Martindale RG. The critical care obesity paradox and implications for nutrition support. Curr Gastro Rep. 2016;18(9):1–8. doi:10.1007/s11894-016-0519-8
   PubMedGoogle Scholar
• Oussaada SM, van Galen KA, Cooiman MI, et al. The pathogenesis of obesity. Metabolism. 2019;92:26–36. doi:10.1016/j.metabol.2018.12.012
   PubMed Web of Science ®Google Scholar
• Sanmiguel C, Gupta A, Mayer EA. Gut microbiome and obesity: a plausible explanation for obesity. Curr Obesity Rep. 2015;4(2):250–261. doi:10.1007/s13679-015-0152-0
   PubMedGoogle Scholar
• Rodriguez J, Delzenne NM. Modulation of the gut microbiota-adipose tissue-muscle interactions by prebiotics. J Endocrinol. 2021;249(1):R1–R23. doi:10.1530/JOE-20-0499
   PubMed Web of Science ®Google Scholar
• Muscogiuri G, Cantone E, Cassarano S, et al. Gut microbiota: a new path to treat obesity. Int J Obesity Suppl. 2019;9(1):10–19. doi:10.1038/s41367-019-0011-7
   PubMedGoogle Scholar
• Pandey R, Kumar N, Paroha S, et al. Impact of obesity and diabetes on arthritis: an update. Health. 2013;5(1):143. doi:10.4236/health.2013.51019
   PubMedGoogle Scholar
• Elagizi A, Kachur S, Lavie CJ, et al. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2018;61(2):142–150. doi:10.1016/j.pcad.2018.07.003
   PubMed Web of Science ®Google Scholar
• Vecchié A, Dallegri F, Carbone F, et al. Obesity phenotypes and their paradoxical association with cardiovascular diseases. Eur J Internal Med. 2018;48:6–17. doi:10.1016/j.ejim.2017.10.020
   PubMed Web of Science ®Google Scholar
• Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med. 2004;10(4):355–361. doi:10.1038/nm1025
   PubMed Web of Science ®Google Scholar
• Tham DM, Martin-McNulty B, Wang YX, et al. Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiol Genom. 2002;11(1):21–30. doi:10.1152/physiolgenomics.00062.2002
   PubMed Web of Science ®Google Scholar
• So I, Yadav H. Obesity and Its Complications Pathogenesis. In: Pathophysiology of Obesity-Induced Health Complications. Springer; 2020:43–56.
   Google Scholar
• Höhn S, Dozières-Puyravel B, Auvin S. History of dietary treatment: guelpa & Marie first report of intermittent fasting for epilepsy in 1911. Epilepsy Behav. 2019;94:277–280. doi:10.1016/j.yebeh.2019.03.018
   PubMed Web of Science ®Google Scholar
• Freeman J, Veggiotti P, Lanzi G, Tagliabue A, Perucca E. The ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Res. 2006;68(2):145–180.
   PubMed Web of Science ®Google Scholar
• Goday A, Bellido D, Sajoux I, et al. Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus. Nut Diabetes. 2016;6(9):e230–e30. doi:10.1038/nutd.2016.36
   Google Scholar
• Liu H, Yang Y, Wang Y, et al. Ketogenic diet for treatment of intractable epilepsy in adults: a meta‐analysis of observational studies. Epilepsia Open. 2018;3(1):9–17. doi:10.1002/epi4.12098
   PubMedGoogle Scholar
• Blackford R. Not your parents’ ketogenic diet–Flexibility in 2020. Epilepsy Res. 2020;162:106307. doi:10.1016/j.eplepsyres.2020.106307
   PubMed Web of Science ®Google Scholar
• Kossoff EH, Zupec‐Kania BA, Auvin S, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group. Epilepsia open. 2018;3(2):175–192. doi:10.1002/epi4.12225
   PubMedGoogle Scholar
• Liu Y-M, Wang H-S. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed j. 2013;36(1):9–15. doi:10.4103/2319-4170.107154
   PubMedGoogle Scholar
• Sondhi V, Agarwala A, Pandey RM, et al. Efficacy of ketogenic diet, modified Atkins diet, and low glycemic index therapy diet among children with drug-resistant epilepsy: a randomized clinical trial. JAMA Pediatr. 2020;174(10):944–951. doi:10.1001/jamapediatrics.2020.2282
   PubMed Web of Science ®Google Scholar
• Jagadish S, Payne ET, Wong-Kisiel L, Nickels KC, Eckert S, Wirrell EC. The ketogenic and modified Atkins diet therapy for children with refractory epilepsy of genetic etiology. Pediatr Neurol. 2019;94:32–37. doi:10.1016/j.pediatrneurol.2018.12.012
   PubMed Web of Science ®Google Scholar
• Hartman AL, Gasior M, Vining EP, Rogawski MA. The neuropharmacology of the ketogenic diet. Pediatr Neurol. 2007;36(5):281–292. doi:10.1016/j.pediatrneurol.2007.02.008
   PubMed Web of Science ®Google Scholar
• Cahill GF. Fuel metabolism in starvation. Annu Rev Nutr. 2006;26(1):1–22. doi:10.1146/annurev.nutr.26.061505.111258
   PubMedGoogle Scholar
• Puchalska P, Crawford PA. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab. 2017;25(2):262–284. doi:10.1016/j.cmet.2016.12.022
   PubMed Web of Science ®Google Scholar
• Paoli A, Bosco G, Camporesi EM, Mangar D. Ketosis, ketogenic diet and food intake control: a complex relationship. Frontiers in Psychology. 2015;6:27. doi:10.3389/fpsyg.2015.00027
   PubMed Web of Science ®Google Scholar
• Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer–where do we stand? Mol Metabol. 2020;33:102–121. doi:10.1016/j.molmet.2019.06.026
   PubMed Web of Science ®Google Scholar
• Crawford P. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Biophys J. 2019;116(3):2a. doi:10.1016/j.bpj.2018.11.034
   Web of Science ®Google Scholar
• Douris N, Melman T, Pecherer JM, et al. Adaptive changes in amino acid metabolism permit normal longevity in mice consuming a low-carbohydrate ketogenic diet. BBA. 2015;1852(10):2056–2065. doi:10.1016/j.bbadis.2015.07.009
   PubMed Web of Science ®Google Scholar
• Saisho Y, Butler AE, Manesso E, Elashoff D, Rizza RA, Butler PC. β-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care. 2013;36(1):111–117. doi:10.2337/dc12-0421
   PubMed Web of Science ®Google Scholar
• Qinghua C, Weining C. Impact of sodium ozagrel on levels of TXB_2 and 6-Keto-Pgf_1α in elderly patients with coronary heart disease and its significance. China Pharma. 2013;2:1.
   Google Scholar
• Sumithran P, Prendergast LA, Delbridge E, et al. Ketosis and appetite-mediating nutrients and hormones after weight loss. Eur J Clin Nutr. 2013;67(7):759–764. doi:10.1038/ejcn.2013.90
   PubMed Web of Science ®Google Scholar
• Samaha FF, Iqbal N, Seshadri P, et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med. 2003;348(21):2074–2081. doi:10.1056/NEJMoa022637
   PubMed Web of Science ®Google Scholar
• Deemer SE, Plaisance EP, Martins C. Impact of ketosis on appetite regulation—a review. Nutr Res. 2020;77:1–11. doi:10.1016/j.nutres.2020.02.010
   PubMed Web of Science ®Google Scholar
• Veldhorst MA, Westerterp-Plantenga MS, Westerterp KR. Gluconeogenesis and energy expenditure after a high-protein, carbohydrate-free diet. The American Journal of Clinical Nutrition. 2009;90(3):519–526. doi:10.3945/ajcn.2009.27834
   PubMed Web of Science ®Google Scholar
• Tagliabue A, Bertoli S, Trentani C, Borrelli P, Veggiotti P. Effects of the ketogenic diet on nutritional status, resting energy expenditure, and substrate oxidation in patients with medically refractory epilepsy: a 6-month prospective observational study. Clin Nutr. 2012;31(2):246–249. doi:10.1016/j.clnu.2011.09.012
   PubMed Web of Science ®Google Scholar
• Paoli A, Cenci L, Fancelli M, et al. Ketogenic diet and phytoextracts Comparison of the efficacy of Mediterranean, zone and tisanoreica diet on some health risk factors; 2010.
   Google Scholar
• Fine EJ, Feinman RD. Thermodynamics of weight loss diets. Nutr Metab. 2004;1(1):1–8. doi:10.1186/1743-7075-1-15
   Google Scholar
• Feinman RD, Fine EJ. Nonequilibrium thermodynamics and energy efficiency in weight loss diets. Theor Biol Med Modell. 2007;4(1):1–13. doi:10.1186/1742-4682-4-27
   PubMedGoogle Scholar
• Macfarlane G, Gibson G, Beatty E, Cummings J. Estimation of short-chain fatty acid production from protein by human intestinal bacteria based on branched-chain fatty acid measurements. FEMS Microbiol Ecol. 1992;10(2):81–88. doi:10.1111/j.1574-6941.1992.tb00002.x
   Google Scholar
• O’Callaghan A, Van Sinderen D. Bifidobacteria and their role as members of the human gut microbiota. Front Microbiol. 2016;2:925.
   Google Scholar
• Paoli A. Ketogenic diet for obesity: friend or foe? Int J Environ Res Public Health. 2014;11(2):2092–2107. doi:10.3390/ijerph110202092
   PubMed Web of Science ®Google Scholar
• Gower BA, Goss AM. A lower-carbohydrate, higher-fat diet reduces abdominal and intermuscular fat and increases insulin sensitivity in adults at risk of type 2 diabetes. J Nutr. 2015;145(1):177S–183S. doi:10.3945/jn.114.195065
   PubMed Web of Science ®Google Scholar
• Simeone KA, Matthews SA, Rho JM, Simeone TA. Ketogenic diet treatment increases longevity in Kcna1‐null mice, a model of sudden unexpected death in epilepsy. Epilepsia. 2016;57(8):e178–e82. doi:10.1111/epi.13444
   PubMed Web of Science ®Google Scholar
• Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev. 2009;59(2):293–315. doi:10.1016/j.brainresrev.2008.09.002
   PubMedGoogle Scholar
• Abduraman MA, Azizan NA, Teoh SH, Tan ML. Ketogenesis and SIRT1 as a tool in managing obesity. Obes Res Clin Pract. 2021;15(1):10–18. doi:10.1016/j.orcp.2020.12.001
   PubMed Web of Science ®Google Scholar
• Calcaterra V, Verduci E, Pascuzzi MC, et al. Metabolic derangement in pediatric patient with obesity: the role of ketogenic diet as therapeutic tool. Nutrients. 2021;13(8):2805. doi:10.3390/nu13082805
   PubMed Web of Science ®Google Scholar
• Armeno M, Caraballo R, Vaccarezza M, et al. National consensus on the ketogenic diet. Rev Neurol. 2014;59(5):213–223. doi:10.33588/rn.5905.2014277
   PubMed Web of Science ®Google Scholar
• Bueno NB, de Melo ISV, de Oliveira SL, da Rocha Ataide T. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr. 2013;110(7):1178–1187. doi:10.1017/S0007114513000548
   PubMed Web of Science ®Google Scholar
• Cox N, Gibas S, Salisbury M, Gomer J, Gibas K. Ketogenic diets potentially reverse Type II diabetes and ameliorate clinical depression: a case study. Diabetes Metabol Synd. 2019;13(2):1475–1479. doi:10.1016/j.dsx.2019.01.055
   PubMed Web of Science ®Google Scholar
• Castaldo G, Palmieri V, Galdo G, et al. Aggressive nutritional strategy in morbid obesity in clinical practice: safety, feasibility, and effects on metabolic and haemodynamic risk factors. Obes Res Clin Pract. 2016;10(2):169–177. doi:10.1016/j.orcp.2015.05.001
   PubMed Web of Science ®Google Scholar
• Xu J, Lloyd DJ, Hale C, et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes. 2009;58(1):250–259. doi:10.2337/db08-0392
   PubMed Web of Science ®Google Scholar
• Jin W, Patti M-E. Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes. Clin Sci. 2009;116(2):99–111. doi:10.1042/CS20080090
   Web of Science ®Google Scholar
• Watanabe M, Tozzi R, Risi R, et al. Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: a comprehensive review of the literature. Obesity Rev. 2020;21(8):e13024. doi:10.1111/obr.13024
   PubMed Web of Science ®Google Scholar
• Gibson AA, Seimon RV, Lee CM, et al. Do ketogenic diets really suppress appetite? A systematic review and meta‐analysis. Obesity Rev. 2015;16(1):64–76. doi:10.1111/obr.12230
   PubMed Web of Science ®Google Scholar
• Youm Y-H, Nguyen KY, Grant RW, et al. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease. Nature Med. 2015;21(3):263–269. doi:10.1038/nm.3804
   PubMed Web of Science ®Google Scholar
• Paoli A, Mancin L, Giacona MC, Bianco A, Caprio M. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome. J Transl Med. 2020;18(1):1–11. doi:10.1186/s12967-020-02277-0
   PubMed Web of Science ®Google Scholar
• Farrés J, Pujol A, Coma M, et al. Revealing the molecular relationship between type 2 diabetes and the metabolic changes induced by a very-low-carbohydrate low-fat ketogenic diet. Nutr Metab. 2010;7(1):1–9. doi:10.1186/1743-7075-7-88
   Google Scholar